Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179508726> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W3179508726 endingPage "1871" @default.
- W3179508726 startingPage "1865" @default.
- W3179508726 abstract "Renal allograft survival is negatively affected by the development of de novo posttransplant donor-specific antibodies (dnDSA). We sought to determine whether treatment with intravenous immunoglobulin (IVIG) could remove or reduce the intensity of dnDSA. A single-center study of 12 recipients with dnDSA and stable function who received IVIG 1 g/kg monthly for 6 months were compared with a contemporaneous cohort of 24 recipients with dnDSA who did not receive IVIG. The median time to first dnDSA was 6 months (interquartile range [IQR], 1-12), and follow-up was 83 months (IQR, 58-94) posttransplant. Resolution of dnDSA occurred in 27% of IVIG vs 46% of control recipients (P = .48). Fifty-eight percent of recipients in both cohorts demonstrated a reduction in the intensity of the dominant DSA at last follow-up (P =1.0). A reduction in the number of dnDSAs occurred in 58% vs 62% of the IVIG and control cohorts, respectively (P = .81). Post-dnDSA, acute rejection occurred in 8% of the IVIG vs 42% in the control group (P = .06). Forty-two percent of IVIG-treated vs 49% of control recipients had a deterioration in function from first dnDSA until most recent follow-up (P = .81). Actuarial graft survivals were equivalent between groups. IVIG treatment of dnDSA in recipients with stable graft function had no impact on DSA clearance or MFI reduction, but this outcome may also be owing to sample size. Larger studies or alternate dosing regimens may be required to determine if there is any role for the use of IVIG as a treatment for dnDSA." @default.
- W3179508726 created "2021-07-19" @default.
- W3179508726 creator A5001506348 @default.
- W3179508726 creator A5004937001 @default.
- W3179508726 creator A5064423706 @default.
- W3179508726 creator A5074276627 @default.
- W3179508726 creator A5075091136 @default.
- W3179508726 creator A5076340862 @default.
- W3179508726 creator A5080360864 @default.
- W3179508726 creator A5081825134 @default.
- W3179508726 date "2021-07-01" @default.
- W3179508726 modified "2023-09-27" @default.
- W3179508726 title "Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies" @default.
- W3179508726 cites W1486598251 @default.
- W3179508726 cites W1983537514 @default.
- W3179508726 cites W1999123359 @default.
- W3179508726 cites W2020425148 @default.
- W3179508726 cites W2060214204 @default.
- W3179508726 cites W2088293372 @default.
- W3179508726 cites W2116180543 @default.
- W3179508726 cites W2123640224 @default.
- W3179508726 cites W2139856839 @default.
- W3179508726 cites W2335513291 @default.
- W3179508726 cites W2616639792 @default.
- W3179508726 cites W2731486760 @default.
- W3179508726 cites W2757341623 @default.
- W3179508726 cites W2775369920 @default.
- W3179508726 doi "https://doi.org/10.1016/j.transproceed.2021.05.011" @default.
- W3179508726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34247857" @default.
- W3179508726 hasPublicationYear "2021" @default.
- W3179508726 type Work @default.
- W3179508726 sameAs 3179508726 @default.
- W3179508726 citedByCount "0" @default.
- W3179508726 crossrefType "journal-article" @default.
- W3179508726 hasAuthorship W3179508726A5001506348 @default.
- W3179508726 hasAuthorship W3179508726A5004937001 @default.
- W3179508726 hasAuthorship W3179508726A5064423706 @default.
- W3179508726 hasAuthorship W3179508726A5074276627 @default.
- W3179508726 hasAuthorship W3179508726A5075091136 @default.
- W3179508726 hasAuthorship W3179508726A5076340862 @default.
- W3179508726 hasAuthorship W3179508726A5080360864 @default.
- W3179508726 hasAuthorship W3179508726A5081825134 @default.
- W3179508726 hasConcept C119060515 @default.
- W3179508726 hasConcept C126322002 @default.
- W3179508726 hasConcept C126894567 @default.
- W3179508726 hasConcept C159641895 @default.
- W3179508726 hasConcept C159654299 @default.
- W3179508726 hasConcept C203014093 @default.
- W3179508726 hasConcept C2777288759 @default.
- W3179508726 hasConcept C2780073493 @default.
- W3179508726 hasConcept C2780252810 @default.
- W3179508726 hasConcept C2780303639 @default.
- W3179508726 hasConcept C2911091166 @default.
- W3179508726 hasConcept C3019514911 @default.
- W3179508726 hasConcept C71924100 @default.
- W3179508726 hasConcept C72563966 @default.
- W3179508726 hasConcept C90924648 @default.
- W3179508726 hasConceptScore W3179508726C119060515 @default.
- W3179508726 hasConceptScore W3179508726C126322002 @default.
- W3179508726 hasConceptScore W3179508726C126894567 @default.
- W3179508726 hasConceptScore W3179508726C159641895 @default.
- W3179508726 hasConceptScore W3179508726C159654299 @default.
- W3179508726 hasConceptScore W3179508726C203014093 @default.
- W3179508726 hasConceptScore W3179508726C2777288759 @default.
- W3179508726 hasConceptScore W3179508726C2780073493 @default.
- W3179508726 hasConceptScore W3179508726C2780252810 @default.
- W3179508726 hasConceptScore W3179508726C2780303639 @default.
- W3179508726 hasConceptScore W3179508726C2911091166 @default.
- W3179508726 hasConceptScore W3179508726C3019514911 @default.
- W3179508726 hasConceptScore W3179508726C71924100 @default.
- W3179508726 hasConceptScore W3179508726C72563966 @default.
- W3179508726 hasConceptScore W3179508726C90924648 @default.
- W3179508726 hasIssue "6" @default.
- W3179508726 hasLocation W31795087261 @default.
- W3179508726 hasOpenAccess W3179508726 @default.
- W3179508726 hasPrimaryLocation W31795087261 @default.
- W3179508726 hasRelatedWork W1486584413 @default.
- W3179508726 hasRelatedWork W2032706825 @default.
- W3179508726 hasRelatedWork W2052365623 @default.
- W3179508726 hasRelatedWork W2055890431 @default.
- W3179508726 hasRelatedWork W2057091235 @default.
- W3179508726 hasRelatedWork W2087086071 @default.
- W3179508726 hasRelatedWork W2098895547 @default.
- W3179508726 hasRelatedWork W2358094500 @default.
- W3179508726 hasRelatedWork W3162193073 @default.
- W3179508726 hasRelatedWork W4287190190 @default.
- W3179508726 hasVolume "53" @default.
- W3179508726 isParatext "false" @default.
- W3179508726 isRetracted "false" @default.
- W3179508726 magId "3179508726" @default.
- W3179508726 workType "article" @default.